NXGL | NEXGEL, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	3.40 - 3.60
52 Week Range	1.8400 - 5.10
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	54,000
Average Volume	129,972
Shares Outstanding	6,790,777
Market Cap	23,292,365
Sector	Healthcare
Industry	Medical - Instruments & Supplies
IPO Date	2021-12-22

Valuation
Profitability
Growth
Health
P/E Ratio	-5.81
Forward P/E Ratio	N/A
EPS	-0.59
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	19
Country	USA
Website	NXGL

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

NXGL's peers: GCTK, AVGR, BNGO, ISRG, GMVD, POAI, PDEX, ZJYL, NYXH, DXR, MLSS, STSS, LUCY, NXGLW

*Chart delayed

Analyzing fundamentals for NXGL we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see NXGL Fundamentals page.

Watching at NXGL technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on NXGL Technicals page.